COVID-19 Vaccine Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals by 30Seconds Health

Family Health
a month ago
COVID-19 Vaccine Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals

The U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 vaccine and the Moderna COVID-19 vaccine to allow for the use of an additional dose in certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices is scheduled to meet Friday, August, 20, 2021, to discuss further clinical recommendations regarding immunocompromised individuals. The action does not apply to people who are not immunocompromised.

“The country has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease. After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna vaccines,” said Acting FDA Commissioner Dr. Janet Woodcock. “Today’s action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID-19. As we’ve previously stated, other individuals who are fully vaccinated are adequately protected and do not need an additional dose of COVID-19 vaccine at this time. The FDA is actively engaged in a science-based, rigorous process with our federal partners to consider whether an additional dose may be needed in the future.”

People who are immunocompromised in a manner similar to those who have undergone solid organ transplantation have a reduced ability to fight infections and other diseases, and they are especially vulnerable to infections, including COVID-19. The FDA evaluated information on the use of a third dose of the Pfizer-BioNTech or Moderna vaccines in these individuals and determined that the administration of third vaccine doses may increase protection in this population. These patients should be counseled to maintain physical precautions to help prevent COVID-19. In addition, close contacts of immunocompromised persons should get vaccinated, as appropriate for their health status, to provide increased protection to their loved ones.

It is recommended that immunocompromised individuals discuss monoclonal antibody treatment options with their health care provider should they contract or be exposed to COVID-19. The FDA has authorized monoclonal antibody treatments for emergency use during this public health emergency for adults and pediatric patients (ages 12 and older weighing at least 88 pounds) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or hospitalization. One authorized product includes use for preventative (prophylaxis) treatment after being exposed to SARS-CoV-2; however, this product is not a substitute for vaccination.

The Pfizer-BioNTech COVID-19 vaccine is currently authorized for emergency use in individuals ages 12 and older, and the Moderna COVID-19 vaccine is authorized for emergency use in individuals ages 18 and older. Both vaccines are administered as a series of two shots: the Pfizer-BioNTech COVID-19 vaccine is administered three weeks apart, and the Moderna COVID-19 vaccine is administered one month apart. The authorizations for these vaccines have been amended to allow for an additional, or third, dose to be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.

The content on 30Seconds.com is for informational and entertainment purposes only, and should not be considered medical advice. The information on this site should not be used to diagnose or treat a health problem or disease, and is not a substitute for professional care. Always consult your personal healthcare provider. The opinions or views expressed on 30Seconds.com do not necessarily represent those of 30Seconds or any of its employees, corporate partners or affiliates.

Take 30 seconds and join the 30Seconds community, and follow us on Facebook to get inspiration in your newsfeed daily. Inspire and be inspired.

Related Products on Amazon We Think You May Like:

30Second Mobile, Inc. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.

My Second COVID-19 Vaccine: Here’s What Happened When I Got the Second Pfizer Coronavirus Vaccination

St. Jude Pediatric Virologist Reacts to FDA Emergency Authorization of Pfizer Vaccine for Kids Ages 12 to 15

Fully Vaccinated From COVID-19: So You’re Finally Fully Vaccinated, But What Does That Mean?

American Academy of Pediatrics Urges In-Person Learning & Wearing of Face Masks in Updated COVID-19 Guidance on School Safety

Elisa A. Schmitz 30Seconds
Such an evolving situation - we learn more every day and have to adapt. Thanks for sharing this update.
Tribe
I am waiting to see if my doctor recommends me for this.
Cassiday
Good to know this! 🙏🏼

join discussion

Please login to comment.

recommended tips

Leaky Gut Syndrome FAQ: ​I Love My Pizza, But Does Gluten Cause Leaky Gut Syndrome?

St. Jude Pediatric Infectious Disease Expert Says Children Are in a Very Dangerous Moment: ​240% Increase in Childhood COVID-19 Cases Since July

Signs of Liver Damage: 4 Surprising Signs & Symptoms That Your Liver May Be in Trouble

Got 30 seconds? Sign up for 30Seconds.com and get the best of our tips each week!